Dr. Davinder S. Grover, MD, MPH

Dr. Grover practices at Glaucoma Associates of Texas PA in Plano, Texas.

Dr. Grover's NPI, 1194861674, was assigned on January 30, 2007. Dr. Grover graduated from The Johns Hopkins University School of Medicine in 2005. Dr. Grover's Texas license number on file is N6331.

Dr. Grover's primary practice is Glaucoma Associates of Texas PA, at 6000 W Spring Creek Pkwy, Plano, TX 75024 in Collin County. The practice phone is (214) 360-0000.

Dr. Grover's primary practice is Glaucoma Associates of Texas PA in Plano, Texas. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Grover to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grover practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Grover's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Grover is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Grover's licenses on file in 3 states: Texas, Maryland and Florida.

Dmand AI lists cataract, cataract surgery with lens implant, conjunctivitis, eyelid inflammation, glaucoma, glaucoma surgery, inflammation of iris and secondary membranaous cataract surgery among the conditions Dr. Grover treats.

CMS data shows 5,142 Medicare services from Dr. Grover across 23 procedure codes in 2024, for 1,021 Medicare patients. Medicare paid $388,116 for them.

CMS counts 1,021 Medicare patients who saw Dr. Grover in 2024. The largest group is 75 to 84, with 449 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Grover's median patient age at 72, with 54% women.

In 2024, Dr. Grover wrote 6,431 Medicare Part D claims for 1,477 patients. 62% of them were for generic drugs. CMS names the drug for 6,299 of them, across 23 drugs with 11 or more claims each, at $286,731 in total drug cost. In 2023, CMS named 6,334 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Grover for performance year 2024, reported as part of a group. Dr. Grover accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 269 procedures of cataract surgery by Dr. Grover, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 65 papers to Dr. Grover, published from 2004 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Intraocular Pressure, Glaucoma, Open-Angle and Trabeculectomy. Dr. Grover has published most often in J Glaucoma. Dr. Grover's most frequent co-authors are Ronald Leigh Fellman, MD, Oluwatosin Urowoli Smith, MD and David Gray Godfrey, MD.

Dmand AI links Dr. Grover to 4 clinical trials. Conditions studied include Glaucoma, Glaucoma, Open-Angle and Ocular Hypertension. InnFocus Inc. sponsors the most, 2.

CMS Open Payments shows 1,154 general payments to Dr. Grover from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. Allergan Inc. paid the most, $463,665. It also lists 9 research payments totaling $150,418 from 2018 to 2025.

Dmand AI lists 2 awards for Dr. Grover, most recently CMS Stage 1 EHR in 2013.

Dr. Grover graduated from The Johns Hopkins University School of Medicine in 2005. Dr. Grover is a member of AAO.

Dr. Grover is in network with 7 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.